George Thom

1.0k total citations
22 papers, 722 citations indexed

About

George Thom is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, George Thom has authored 22 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in George Thom's work include Monoclonal and Polyclonal Antibodies Research (10 papers), RNA and protein synthesis mechanisms (8 papers) and RNA modifications and cancer (5 papers). George Thom is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), RNA and protein synthesis mechanisms (8 papers) and RNA modifications and cancer (5 papers). George Thom collaborates with scholars based in United Kingdom, United States and Germany. George Thom's co-authors include Carl I. Webster, Nancy Standart, Nicola Minshall, Matthew Burrell, Danica Stanimirovic, Eric Brunette, Arsalan S. Haqqani, Ian Gurrell, Stefan Lundquist and Jon P. Hatcher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Biochemical Journal.

In The Last Decade

George Thom

21 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Thom United Kingdom 15 462 189 117 107 81 22 722
Margaret Kenrick United States 5 327 0.7× 219 1.2× 82 0.7× 141 1.3× 115 1.4× 5 712
B. Thillaye–Goldenberg France 18 248 0.5× 105 0.6× 173 1.5× 56 0.5× 36 0.4× 21 716
Jeomil Bae South Korea 11 390 0.8× 112 0.6× 143 1.2× 25 0.2× 167 2.1× 16 647
Piroska E. Rakoczy Australia 17 1.0k 2.3× 365 1.9× 75 0.6× 53 0.5× 30 0.4× 39 1.5k
Hiroyuki Sonoda Japan 13 305 0.7× 116 0.6× 37 0.3× 56 0.5× 56 0.7× 37 723
Chang Sik Cho South Korea 15 507 1.1× 74 0.4× 47 0.4× 39 0.4× 46 0.6× 26 739
Martin Siegemund Germany 9 228 0.5× 76 0.4× 137 1.2× 34 0.3× 98 1.2× 14 387
Jianguo Fan United States 17 545 1.2× 35 0.2× 55 0.5× 35 0.3× 155 1.9× 37 737
Sowmya Parameswaran India 14 451 1.0× 116 0.6× 41 0.4× 22 0.2× 62 0.8× 40 637
Hiroshi Mamada Japan 15 514 1.1× 80 0.4× 259 2.2× 115 1.1× 65 0.8× 22 971

Countries citing papers authored by George Thom

Since Specialization
Citations

This map shows the geographic impact of George Thom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Thom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Thom more than expected).

Fields of papers citing papers by George Thom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Thom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Thom. The network helps show where George Thom may publish in the future.

Co-authorship network of co-authors of George Thom

This figure shows the co-authorship network connecting the top 25 collaborators of George Thom. A scholar is included among the top collaborators of George Thom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Thom. George Thom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thom, George, Sandra Wimberger, Mike Firth, et al.. (2025). Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems. Nature Communications. 16(1). 4290–4290. 1 indexed citations
2.
Madeyski-Bengtson, Katja, Euan Gordon, George Thom, et al.. (2025). Modified pegRNAs mitigate scaffold-derived prime editing by-products. Nature Communications. 16(1). 3374–3374. 2 indexed citations
3.
Hutchinson, James C., R. D. Shannon, Aditya Murthy, et al.. (2025). Physicochemical and functional assessment of messenger RNA 5′Cap-end impurities under forced degradation conditions. Molecular Therapy — Nucleic Acids. 36(2). 102570–102570.
4.
Tkaczyk, Christine, George Thom, Olalekan Daramola, et al.. (2024). In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection. Molecular Therapy. 32(8). 2505–2518. 3 indexed citations
5.
Hammond, Suzan M., Frank Abendroth, Matthew Burrell, et al.. (2022). Antibody-oligonucleotide conjugate achieves CNS delivery in animal models for spinal muscular atrophy. JCI Insight. 7(24). 34 indexed citations
6.
Thom, George, Jon P. Hatcher, Natalia Rodrigo Melero, et al.. (2018). A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. Journal of Cerebral Blood Flow & Metabolism. 39(10). 2074–2088. 31 indexed citations
7.
Haqqani, Arsalan S., George Thom, Matthew Burrell, et al.. (2018). Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity. Journal of Neurochemistry. 146(6). 735–752. 65 indexed citations
8.
Webster, Carl I., Nadia L. Caram‐Salas, Arsalan S. Haqqani, et al.. (2016). Brain penetration, target engagement, and disposition of the blood‐brain barrier‐crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1. The FASEB Journal. 30(5). 1927–1940. 63 indexed citations
9.
10.
11.
Thom, George & Maria Groves. (2012). Ribosome Display. Methods in molecular biology. 901. 101–116. 5 indexed citations
12.
Thom, George & Ralph Minter. (2011). Optimization of CAT-354, a Therapeutic Antibody Directed Against Interleukin-13, Using Ribosome Display. Methods in molecular biology. 805. 393–401. 8 indexed citations
13.
Stewart, Ross, George Thom, Robert Holgate, et al.. (2011). A variant human IgG1-Fc mediates improved ADCC. Protein Engineering Design and Selection. 24(9). 671–678. 31 indexed citations
14.
Vugmeyster, Yulia, Heath Guay, Pamela Szklut, et al.. (2010). In vitro potency, pharmacokinetic profiles and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus. mAbs. 2(3). 335–346. 33 indexed citations
15.
Thom, George, et al.. (2006). Probing a protein–protein interaction by in vitro evolution. Proceedings of the National Academy of Sciences. 103(20). 7619–7624. 61 indexed citations
16.
Thom, George, Nicola Minshall, Anna Git, Joanna Argasinska, & Nancy Standart. (2003). Role of cdc2 kinase phosphorylation and conserved N-terminal proteolysis motifs in cytoplasmic polyadenylation-element-binding protein (CPEB) complex dissociation and degradation. Biochemical Journal. 370(1). 91–100. 24 indexed citations
17.
Minshall, Nicola, George Thom, & Nancy Standart. (2001). A conserved role of a DEAD box helicase in mRNA masking. RNA. 7(12). 1728–1742. 126 indexed citations
18.
Thom, George & Catherine D. Prescott. (1997). The selection in vivo and characterization of an RNA recognition motif for spectinomycin. Bioorganic & Medicinal Chemistry. 5(6). 1081–1086. 16 indexed citations
19.
Leelayuwat, Chanvit, Peter Hollingsworth, Ganjana Lertmemongkolchai, et al.. (1996). Antibody reactivity profiles following immunization with diverse peptides of the PERB11 (MIC) family. Clinical & Experimental Immunology. 106(3). 568–576. 15 indexed citations
20.
Howard, Bruce H., et al.. (1995). Fragmentation of the ribosome to investigate RNA–ligand interactions. Biochemistry and Cell Biology. 73(11-12). 1161–1166. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret Kenrick Breakdown of academic impact, for papers by B. Thillaye–Goldenberg Breakdown of academic impact, for papers by Jeomil Bae Breakdown of academic impact, for papers by Piroska E. Rakoczy Breakdown of academic impact, for papers by Hiroyuki Sonoda Breakdown of academic impact, for papers by Chang Sik Cho Breakdown of academic impact, for papers by Martin Siegemund Breakdown of academic impact, for papers by Jianguo Fan Breakdown of academic impact, for papers by Sowmya Parameswaran Breakdown of academic impact, for papers by Hiroshi Mamada
Rankless by CCL
2026